Legal & General Group Plc acquired a new position in National HealthCare Corporation (NYSEAMERICAN:NHC – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 31,155 shares of the company’s stock, valued at approximately $6,585,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Mariner LLC boosted its position in shares of National HealthCare by 0.9% during the 4th quarter. Mariner LLC now owns 6,839 shares of the company’s stock worth $938,000 after purchasing an additional 59 shares in the last quarter. EverSource Wealth Advisors LLC grew its stake in shares of National HealthCare by 28.5% during the 1st quarter. EverSource Wealth Advisors LLC now owns 311 shares of the company’s stock worth $50,000 after purchasing an additional 69 shares during the period. The Manufacturers Life Insurance Company increased its holdings in shares of National HealthCare by 1.2% in the 1st quarter. The Manufacturers Life Insurance Company now owns 6,048 shares of the company’s stock valued at $966,000 after purchasing an additional 70 shares in the last quarter. ProShare Advisors LLC increased its holdings in shares of National HealthCare by 3.3% in the 4th quarter. ProShare Advisors LLC now owns 2,466 shares of the company’s stock valued at $338,000 after purchasing an additional 78 shares in the last quarter. Finally, Hsbc Holdings PLC lifted its stake in shares of National HealthCare by 1.2% in the first quarter. Hsbc Holdings PLC now owns 7,969 shares of the company’s stock valued at $1,275,000 after purchasing an additional 93 shares during the period. Institutional investors and hedge funds own 56.44% of the company’s stock.
National HealthCare Stock Down 0.7%
NYSEAMERICAN:NHC opened at $217.34 on Thursday. The company has a market capitalization of $3.40 billion, a PE ratio of 24.45 and a beta of 0.62. National HealthCare Corporation has a 52-week low of $111.24 and a 52-week high of $239.29. The stock has a fifty day simple moving average of $220.34 and a 200-day simple moving average of $191.16.
National HealthCare Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Wednesday, September 30th. National HealthCare’s dividend payout ratio is 61.89%.
Analyst Upgrades and Downgrades
A number of analysts recently commented on NHC shares. BMO Capital Markets raised shares of National HealthCare to a “hold” rating in a report on Monday, May 18th. Royal Bank Of Canada upgraded shares of National HealthCare to a “hold” rating in a research report on Monday, May 18th. Robert W. Baird raised National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. Finally, The Goldman Sachs Group raised National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. Two equities research analysts have rated the stock with a Strong Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy”.
Get Our Latest Research Report on NHC
Insider Activity
In other news, CEO Stephen Fowler Flatt sold 1,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $237.08, for a total transaction of $355,620.00. Following the completion of the transaction, the chief executive officer directly owned 65,487 shares of the company’s stock, valued at $15,525,657.96. This trade represents a 2.24% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director David R. Gifford sold 1,779 shares of National HealthCare stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $225.42, for a total value of $401,022.18. Following the transaction, the director owned 1,030 shares of the company’s stock, valued at $232,182.60. This represents a 63.33% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 13.92% of the stock is owned by corporate insiders.
About National HealthCare
National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.
Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.
Featured Stories
- Five stocks we like better than National HealthCare
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Want to see what other hedge funds are holding NHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National HealthCare Corporation (NYSEAMERICAN:NHC – Free Report).
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.
